Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07845630
PHASE1

A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.

Official title: Bioequivalence of Two Different Vicadrostat / Empagliflozin Formulations Following Oral Administration in Healthy Trial Participants (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-10-14

Completion Date

2026-12-21

Last Updated

2026-10-15

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Vicadrostat

Vicadrostat

DRUG

Empagliflozin

Empagliflozin

DRUG

Vicadrostat + empagliflozin

Vicadrostat + empagliflozin combined

Locations (1)

Humanpharmakologisches Zentrum Biberach

Biberach, Germany